Publications

Ikena’s development pipeline is supported by scientific research published by the Ikena R&D team, our collaborators, and by external experts.

Publications

Our pipeline is supported by scientific research performed by our in-house team and by external experts.

For links to relevant scientific publications and abstracts, please see below (subscriptions may be required to access full text of certain publications):

Feb 2016 | From External Experts

Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway

Chan et al. Nature Chemical Biology

Jan 2016 | From External Experts

Immunotherapy of Colon Cancer

Stein and Folprecht Oncology Research and Treatment

Jan 2016 | From External Experts

The role of prostaglandin E2 in tumor associated immunosuppression

Wang, D. and DuBois, R. N. Trends in Molecular Medicine

Sep 2015 | From External Experts

Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?

O'Callaghan, G. and Houston, A. British Journal of Pharmacology

Nov 2014 | From External Experts

Aryl hydrocarbon receptor ligands in cancer: friend and foe

Murray, I., Patterson, A. and Perdew, G. Nature Reviews Cancer

Mar 2014 | From External Experts

YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes

Lorenzetto et al. Oncotarget

Jan 2012 | From External Experts

Regulation of Immune Responses by Prostaglandin E2

Kalinski, P. The Journal of Immunology

Developing breakthrough, patient-directed therapies for difficult to treat cancers.

Ikena™ Approach